Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial

Rathie Rajendram(University College London), Colin Dayan(University Hospital of Wales), Geoffrey E. Rose(University College London), Julie Pell(Cardiff University), Chunhei Li(Cardiff University), Nichola Rumsey(University of the West of England), Daniel G. Ezra(Moorfields Eye Hospital), Anne Cook(Manchester Royal Eye Hospital), Andrew D. Dick(At Bristol), Helen Garrott(Bristol Eye Hospital), Daniel S. Morris(University Hospital of Wales), Robert K. Hills(Cancer Research UK Clinical Trials Unit), Nachi Palaniappan(Velindre Cancer Centre), Fion Bremner(University College London Hospitals NHS Foundation Trust), Peter Taylor(Cardiff University), Catey Bunce(Moorfields Eye Hospital NHS Foundation Trust), Olivia Morris(Moorfields Eye Hospital), Sue Yarrow(Bristol Eye Hospital), Jane M. Olver(Imperial College Healthcare NHS Trust), Jimmy Uddin(Moorfields Eye Hospital), Steven J. Hurel(University College London), Victoria Wilson(University of Bristol), Sue Jackson(University of the West of England), Richard Lee(Moorfields Eye Hospital), Suzannah R. Drummond(NHS Greater Glasgow and Clyde), Mike J. Potts(University Hospitals Bristol NHS Foundation Trust), Carol Lane(University Hospital of Wales), Rajni Jain(Imperial College Healthcare NHS Trust), H. Herbert(University Hospitals Bristol NHS Foundation Trust), Ewan Kemp(Gartnavel General Hospital), Nicola Harris(Moorfields Eye Hospital), Diana Ritchie(Beatson West of Scotland Cancer Centre), Rao Gattamaneni(The Christie NHS Foundation Trust), Nicholas Plowman(Barts Health NHS Trust), Marjorie Tomlinson(Bristol Eye Hospital)
The Lancet Diabetes & Endocrinology
January 31, 2018
Cited by 105


Related Papers